OMNIlife Science receives 510K approval for ApeX-LNK highly Cross Linked polyethylene

Tuesday, 03 March 2009 02:07

OMNI life science, Inc., a medical device company based in Raynham Massachusetts and focused on the design, manufacture and distribution of Orthopaedic Joint Replacement Products, announced today that it had received FDA 510k approval for its proprietary (patent pending) highly cross linked polyethylene. The new product to be called ApeX-LNK Polyethylene will be used to enhance and expand OMNI’s Apex Modular Acetabular Cup system product offering. George Cipolletti, President and CEO of OMNIlife Science said “with the approval of ApeX-LNK we are now able to offer highly cross linked polyethylene to our customers who previously could only obtain this type of technology from our much larger competitors.”